AzTrials
AzTrials

Dentin SensitivityPhase 4NCT07871786

Efficacy of a Sonic Toothbrush and 8% Arginine Toothpaste in Reducing Dentinal Hypersensitivity

A Phase 4 study testing 8.0% Arginine Dentifrice, Electric Sonic Toothbrush and Adult Soft Bristle Manual Toothbrush in people with Dentin Sensitivity and Dentin Hypersensitivity, run by Colgate Palmolive at 1 site in Brazil.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This clinical study evaluates the efficacy of an oral hygiene regimen consisting of an electric sonic toothbrush used in combination with an 8.0% arginine and calcium carbonate toothpaste in reducing dentinal hypersensitivity compared to a manual soft-bristled toothbrush with the same desensitizing toothpaste. Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Dentin Sensitivity, Dentin Hypersensitivity
What is being tested?
8.0% Arginine Dentifrice, Electric Sonic Toothbrush and Adult Soft Bristle Manual Toothbrush
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteBrazil
Study dates
6 Dec 2021to 14 Feb 2022
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Sign an Informed Consent Form.
  • Male or female between 18 and 70 years of age, inclusive.
  • In good general health as determined by the study investigators.
  • Available for the seven (7) days duration of the study.
  • Present two (2) sensitive teeth anterior to the molars demonstrating dentin exposure due to cervical erosion/abrasion and/or gingival recession.
  • Present a qualifying dentin hypersensitivity response to air blast stimuli applied for 1 second to the cervical surface (gingivo-facial 1/3) defined by a score of 2 or 3 on the Schiff Cold Air Sensitivity Scale.

Who cannot join

  • Presence of gross oral pathology, chronic disease, or history of allergies to test products.
  • Use of a desensitizing oral care product or recipient of dental desensitizing treatment within 1 month prior to study start.
  • Advanced periodontal disease or periodontal treatment (including surgery) within 12 months prior to study start (routine dental cleaning is permitted).
  • Sensitive teeth with mobility greater than 1.
  • Sensitive teeth with extensive or defective restorations (including crowns), suspected pulpitis, caries, cracked enamel, or used as abutments for removable partial dentures.
  • Current use of anticonvulsants, antihistamines, antidepressants, sedatives, tranquilizers, anti-inflammatory drugs, or daily use of analgesics that could affect pain sensation.
Show all 11Show fewer
  • Current smokers.
  • Concurrent participation in any other oral clinical study.
  • Self-reported pregnancy or currently breastfeeding.
  • Known allergy to oral care products, personal care consumer products, or their ingredients.
  • Existing medical condition prohibiting fasting from food or liquid for up to 4 hours.

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • The Federal University of Rio Grande do Sul

    Porto Alegre, Rio Grande do Sul, 90040-060

Other trials in Brazil

About this study

Official title: Clinical Investigation to Assess the Efficacy of a Sonic Toothbrush and a Toothpaste Containing 8.0% Arginine and Calcium Carbonate in Reducing Dentinal Hypersensitivity

This clinical study evaluates the efficacy of an oral hygiene regimen consisting of an electric sonic toothbrush used in combination with an 8.0% arginine and calcium carbonate toothpaste in reducing dentinal hypersensitivity compared to a manual soft-bristled toothbrush with the same desensitizing toothpaste. Adult participants with tactile/air-blast hypersensitive teeth brush twice daily for 7 days. Sensitivity reductions are evaluated at baseline, immediately post-brushing, at 3 days, and at 7 days.

Read the detailed description

Dentinal hypersensitivity is a common oral condition characterized by short, sharp pain arising from exposed dentin in response to external stimuli. This single-center, Phase III, randomized, examiner-blind, 2-arm parallel-group clinical trial investigates the efficacy of combining an electric sonic toothbrush with an 8.0% arginine and calcium carbonate toothpaste to alleviate dentinal hypersensitivity.

Eighty adult participants meeting inclusion and exclusion criteria are randomized (1:1 ratio) into two study groups:

  1. Test Group: Electric sonic toothbrush + 8.0% arginine fluoride toothpaste.
  2. Positive Control Group: Adult soft-bristled manual toothbrush + 8.0% arginine fluoride toothpaste.

Sequence of Study Procedures:

  1. Screening \& Baseline Visit (Visit 1): Participants undergo oral soft tissue examinations and air-blast hypersensitivity evaluations. Eligible participants present at least two qualifying sensitive teeth demonstrating cervical erosion/abrasion or gingival recession with a Schiff Cold Air Sensitivity Scale score of 2 or 3.
  2. Immediate Post-Brushing Assessment: Immediately following baseline evaluations, participants perform supervised in-office brushing with their assigned regimen for 2 minutes and 30 seconds, followed by an immediate post-brushing sensitivity re-evaluation.
  3. Home Usage: Participants are dispensed their assigned regimen and instructed to brush for 2 minutes twice daily (morning and evening) for 7 days. 4- Follow-Up Visits: Dentinal hypersensitivity and oral soft tissue status are re-evaluated after 3 days (Visit 2) and 7 days (Visit 3) of product use.
Being tested
8.0% Arginine Dentifrice, Electric Sonic Toothbrush, Adult Soft Bristle Manual Toothbrush
Keywords
Arginine, Sonic Toothbrush, Dentinal Hypersensitivity, Schiff Cold Air Sensitivity Scale
Medical subject headings
Dentin Sensitivity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 8.0% Arginine DentifriceDrug

    Commercial fluoride toothpaste containing 8.0% arginine and calcium carbonate.

  • Electric Sonic ToothbrushDevice

    Commercially available electric sonic toothbrush.

  • Adult Soft Bristle Manual ToothbrushDevice

    Commercially available adult soft bristle manual toothbrush (ADA reference).

Study groups in NCT07871786
Study groupRoleWhat they receive
Test Group (Sonic Toothbrush + 8% Arginine Toothpaste)ExperimentalParticipants brush twice daily (morning and evening) for 2 minutes using an electric sonic toothbrush and an 8.0% arginine fluoride toothpaste for 7 days.
Receives: Drug: 8.0% Arginine Dentifrice; Device: Electric Sonic Toothbrush
Positive Control Group (Manual Toothbrush + 8% Arginine Toothpaste)Active comparatorParticipants brush twice daily (morning and evening) for 2 minutes using an adult soft-bristled manual toothbrush and an 8.0% arginine fluoride toothpaste for 7 days.
Receives: Drug: 8.0% Arginine Dentifrice; Device: Adult Soft Bristle Manual Toothbrush

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Dentinal Hypersensitivity Score (Schiff Cold Air Sensitivity Scale)

    Assessment of tooth sensitivity to air blast stimuli applied for 1 second to the exposed cervical surface of qualifying teeth, scored using the Schiff Cold Air Sensitivity Scale (range 0-3, where 0 = no response and 3 = painful response/requests discontinuation)

    Measured: Baseline, immediately post-brushing, Day 3, and Day 7.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Oct 2026
  2. Study start6 Dec 2021
  3. Primary completion14 Feb 2022
  4. Study completion14 Feb 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Single-center, randomized, examiner-blind, 2-arm parallel-group clinical trial.
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07871786
Sponsor's protocol ID
CRO-2021-06-SEN-ETB-BZ-BS
Status last verified
Oct 2026
First submitted
8 Oct 2026
Last updated
16 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared to maintain confidentiality as outlined in the subject consent and privacy terms.

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing 8.0% Arginine Dentifrice, Electric Sonic Toothbrush and Adult Soft Bristle Manual Toothbrush in people with Dentin Sensitivity and Dentin Hypersensitivity, run by Colgate Palmolive at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Dentinal Hypersensitivity Score (Schiff Cold Air Sensitivity Scale) (time frame: Baseline, immediately post-brushing, Day 3, and Day 7.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in